Skip to main content
. 2013 Feb 22;2(1):e004283. doi: 10.1161/JAHA.112.004283

Table 1.

Characteristics of the MESA (2000–2002) and MASALA (2009–2010) Participants

Variable Overall (n=3516) White (n=1131) Chinese American (n=613) African American (n=766) Latino (n=879) Asian Indian (n=127)
Age, mean±SD 60.7±9.4 61.0±9.3 60.8±9.6 60.9±9.4 60.0±9.5 59.5±8.1
Female sex 1761 (50) 557 (49) 305 (50) 387 (51) 451 (51) 61 (48)
Highest educational attainment
≤High school 1251 (36) 221 (20) 234 (38) 225 (29) 558 (63) 13 (10)
Some college/associates or tech degree 949 (27) 291 (26) 129 (21) 286 (37) 231 (26) 12 (9)
Bachelor's degree 635 (18) 279 (25) 140 (23) 133 (17) 50 (6) 33 (26)
Graduate degree 681 (19) 340 (30) 110 (18) 122 (16) 40 (5) 69 (54)
Family income ≥$75 000 863 (25) 445 (40) 119 (20) 139 (19) 65 (8) 95 (76)
Currently drinks alcohol 1734 (49) 758 (67) 128 (21) 387 (51) 396 (45) 65 (51)
Smoking status
Never smoker 1897 (54) 499 (44) 466 (76) 346 (45) 481 (55) 105 (83)
Past smoker 1192 (34) 505 (45) 114 (19) 274 (36) 282 (32) 17 (13)
Current smoker 427 (12) 127 (11) 33 (5) 146 (19) 116 (13) 5 (4)
BMI (kg/m2), mean±SD 27.9±5.2 27.8±5.0 24.0±3.2 29.6±5.5 29.3±5.1 26.4±4.6
Waist circumference (cm), mean±SD 97.2±14.1 98.5±14.5 86.9±9.7 100.7±14.3 100.1±12.8 94.4±12.2
Fasting glucose, mean±SD 96.9±29.1 90.5±20.0 99.1±29.8 98.2±29.3 101.8±36.5 101.6±26.0
Serum insulin (mU/L), mean±SD 10.6±13.6 9.6±6.1 9.6±13.7 11.2±23.4 11.1±8.3 17.0±8.6
Hypertension 1597 (45) 467 (41) 240 (39) 452 (59) 383 (44) 55 (43)
Glycemic status
Normal 2602 (74) 961 (85) 432 (71) 538 (70) 601 (68) 70 (57)
Impaired fasting glucose 479 (14) 106 (9) 103 (17) 108 (14) 139 (16) 23 (19)
Diabetes 423 (12) 60 (5) 77 (13) 118 (15) 138 (16) 30 (24)
Statin medication use 493 (14) 172 (15) 76 (12) 102 (13) 111 (13) 32 (25)
ACEI or ARB use 407 (12) 114 (10) 33 (5) 115 (15) 116 (13) 29 (23)

MESA indicates Multi‐Ethnic Study of Atherosclerosis; MASALA, Mediators of Atherosclerosis in South Asians Living in America; SD, standard deviation; BMI, body mass index; ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker.